CONMED Corp — Director's Dealing 2022

Aug 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-08-10

Reporting Person: Cohen Heather L (EVP CORP HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-10	Common Stock	M	5000	$32.93	Acquired	29625	Direct
2022-08-10	Common Stock	F	2847	$100.85	Disposed	26778	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-10	Sars (Stock Appreciation Rights)	$32.93	M	5000	Disposed	2023-06-01	Common Stock (5000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.